February 3, 2026

Twist Bioscience Corporation (TWST) Stock Analysis: Unraveling the Growth Potential in Synthetic DNA

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a current market capitalization of $2.87..

Omnicell, Inc. (OMCL) Stock Analysis: Investor Optimism Soars with 15.87% Potential Upside

Omnicell, Inc. (NASDAQ: OMCL) has been catching the attention of investors as it steadily positions itself as a key player in the healthcare sector, particularly within..

Catalyst Pharmaceuticals, Inc. (CPRX): Analyst Ratings Highlight 38% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is making waves in the biotechnology sector with a compelling growth narrative and an impressive analyst outlook. The company, based in..

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Promising 22.77% Upside with Strong Buy Ratings

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its substantial potential upside of 22.77%, according to the latest analyst ratings...

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Potential 8.12% Upside Beckons Investors

Guardian Pharmacy Services, Inc. (GRDN) is catching the eye of investors with its robust performance and promising potential upside. As a key player in the healthcare..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech with 100% Potential Upside and Strong Buy Ratings

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, is creating ripples in the healthcare sector with its innovative approach to immunotherapy. As a commercial-stage company,..

Evotec SE (EVO) Stock Analysis: Exploring a 63.93% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Evotec SE (EVO) an intriguing prospect. With a market capitalization of $1.21 billion, this German-based company is..

AtriCure, Inc. (ATRC) Stock Analysis: A Compelling 43% Upside Potential for Investors

For investors keen on the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents an intriguing opportunity. This Ohio-based company, with a market cap of $1.83 billion, specializes..

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Compelling 21.41% Potential Upside for Investors

Brookdale Senior Living Inc. (NYSE: BKD) stands as a formidable player within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Brentwood, Tennessee,..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Contender with a 108% Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN) has garnered significant attention in the biotechnology sector, offering a compelling opportunity for investors willing to navigate the high-risk, high-reward landscape..

UFP Technologies, Inc. (UFPT) Stock Analysis: Healthcare Innovator with 28.78% Potential Upside

Investors keeping an eye on the medical devices sector may find UFP Technologies, Inc. (UFPT) to be an intriguing opportunity. With a market capitalization of $1.97..

CG Oncology, Inc. (CGON) Stock Analysis: Biotechnology Innovator with a 45.78% Potential Upside

CG Oncology, Inc. (NASDAQ: CGON) is making waves in the biotechnology sector with its promising pipeline of therapeutics aimed at tackling bladder cancer. With a market..

Adaptive Biotechnologies (ADPT) Stock Analysis: Investor Outlook on a Healthcare Innovator with 102% Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands out in the biotechnology sector, not just for its innovative approach to immune medicine but also for its remarkable revenue..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Is a 100% Upside Within Reach?

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a fascinating player in the healthcare sector, specializing in health information services within the United States. With a market..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A 69% Upside Potential in the Biotech Arena

Beam Therapeutics Inc. (NASDAQ: BEAM) stands as a compelling player in the biotechnology sector, with a market capitalization of $2.83 billion. Headquartered in Cambridge, Massachusetts, Beam..

Organon & Co. (OGN) Stock Analysis: Evaluating Healthcare’s Undervalued Opportunity with a 14% Upside

Organon & Co. (NYSE: OGN), a notable player in the healthcare sector, is attracting attention from investors with its diverse portfolio of prescription therapies and medical..

Phreesia, Inc. (PHR): Investor Outlook with 116.74% Potential Upside

Phreesia, Inc. (PHR) is making waves in the healthcare sector with its innovative SaaS-based solutions, offering a robust platform for patient intake and payment services. Based..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 29% Potential Upside in the Medical Devices Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the medical devices industry, is capturing investor attention with a notable potential upside of 29.18%. Headquartered..

LifeStance Health Group, Inc. (LFST): Analyst Consensus Points to 23.8% Upside Potential

Investors eyeing the healthcare sector might find LifeStance Health Group, Inc. (LFST) an intriguing option, given the company’s promising upside potential and its focus on expanding..

Disc Medicine, Inc. (IRON) Investor Outlook: Unveiling a 51% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a promising name in the biotechnology sector, is capturing investor attention with its substantial 51.37% potential upside. This clinical-stage biopharmaceutical company,..

Search

Funds

February 3, 2026

Search

Funds

February 3, 2026

FTSE 100

Funds